CN110025772A - 一种治疗脱发、白发的提取液及其设备 - Google Patents
一种治疗脱发、白发的提取液及其设备 Download PDFInfo
- Publication number
- CN110025772A CN110025772A CN201910304584.4A CN201910304584A CN110025772A CN 110025772 A CN110025772 A CN 110025772A CN 201910304584 A CN201910304584 A CN 201910304584A CN 110025772 A CN110025772 A CN 110025772A
- Authority
- CN
- China
- Prior art keywords
- hair
- extracting solution
- parts
- equipment
- ultrasonic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 34
- 230000003779 hair growth Effects 0.000 title claims abstract description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 12
- 210000003780 hair follicle Anatomy 0.000 claims abstract description 12
- 239000002671 adjuvant Substances 0.000 claims abstract description 10
- 230000004089 microcirculation Effects 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims abstract description 7
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 6
- 244000286838 Eclipta prostrata Species 0.000 claims abstract description 6
- 102000004190 Enzymes Human genes 0.000 claims abstract description 6
- 108090000790 Enzymes Proteins 0.000 claims abstract description 6
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 6
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 229960002477 riboflavin Drugs 0.000 claims abstract description 6
- 239000011780 sodium chloride Substances 0.000 claims abstract description 6
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 6
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 6
- 244000178231 Rosmarinus officinalis Species 0.000 claims abstract description 5
- 210000004761 scalp Anatomy 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000008280 blood Substances 0.000 claims abstract description 3
- 210000004369 blood Anatomy 0.000 claims abstract description 3
- 230000004936 stimulating effect Effects 0.000 claims abstract 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- 235000011201 Ginkgo Nutrition 0.000 claims description 2
- 244000194101 Ginkgo biloba Species 0.000 claims description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 2
- 240000004064 Poterium sanguisorba Species 0.000 claims description 2
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims description 2
- 244000050053 Rosa multiflora Species 0.000 claims description 2
- 235000000656 Rosa multiflora Nutrition 0.000 claims description 2
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims description 2
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 abstract description 6
- 235000015097 nutrients Nutrition 0.000 abstract description 5
- 201000004384 Alopecia Diseases 0.000 abstract description 4
- 231100000360 alopecia Toxicity 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000008081 blood perfusion Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229910000831 Steel Inorganic materials 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 210000000264 venule Anatomy 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 244000226566 Psoralea corylifolia Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 230000009583 hair follicle growth Effects 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000008336 microcirculatory blood flow Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000004918 root sheath Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/18—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with another compound as one donor, and incorporation of one atom of oxygen (1.14.18)
- C12Y114/18001—Tyrosinase (1.14.18.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种治疗脱发、白发的提取液及其设备,提取液中包括迷迭香20‑40份,女贞子10‑20份,旱莲草10‑20份,含量0.8‑0.9%氯化钠,以及由微量络氨酸酶、维生素B2、B6组成的辅助剂;超声治疗设备包括超声池、头罩、上盖、外壳及控制系统。将以上提取液及辅助剂、适量水倒入超声池,加热至选定温度,启动超声波,患者戴上头罩,将需治疗部位浸入超声池液体中,可以加快改善头皮血液微循环,刺激毛囊并促进毛发生长。本发明的有益效果是:通过改善毛囊下后微动脉,增加血流灌注量,增加营养物质满足头发及头皮组织需要,治疗改善脱发和白发。
Description
技术领域:
本发明涉及一种治疗改善脱发、白发的医疗器械,尤其涉及一种治疗脱发、白发的提取液及其设备。
背景技术:
微循环是指微动脉和微静脉之间的血液循环,是血液与组织细胞进行物质交换的场所。正常情况下,微循环血流量与人体组织、器官代谢水平相适应,使人体内各器官生理功能得以正常运行。
微循环功能障碍或微循环血流灌注量减少时,营养物质和氧气不能满足组织代谢的需要,同时组织器官中的废物不能及时排出,导致组织器官功能不全或衰竭,这同样成为许多头皮疾病发生和发展的重要原因。
毛发是皮肤的附属器官,其营养来源于毛囊,而毛囊的好坏决定了毛发生长的色泽,韧性,粗细和数量,所以毛囊才是维护头发的关键所在,在每一个毛囊下都分布着一个后微动脉,为毛囊提供营养物质,这些后微动脉组成了毛细血管网,这个血管网也就是微循环。
如果微循环系统阻塞不通畅,那么就会导致毛囊失去营养来源,毛发无法健康生长最终脱落。
专利CN2012201105558公开了一种生发仪,应用臭氧、负离子及物理按摩的原理,给毛囊以充足的氧气,同时按摩使局部毛细血管扩张,活化周围组织达到养发生发目的。
专利CN201110205967x公开了一种头发毛囊改造剂,是以女贞子、墨旱莲、桑寄生、首乌、覆盆子、赖氨酸、维生素B6、B12等制成药膏,涂抹于脱发部位达到生发目的。
专利CN2018101923464公开了一种植物生发固发液,是以侧伯叶30-40份,生姜10-15份,菟丝子20-35份,白芷25-40份,秦艽5-15份,补骨脂10-20份,茯苓25-35份,纯水100份浸泡提取药液涂抹,促进毛囊生长,达到生发目的。
发明内容:
本发明旨在提供一种治疗脱发、白发的提取液及其设备,通过改善头皮下血管的微循环,促进营养物质吸收,达到治疗脱发、白发目的,满足人们健康、美容的要求。
本发明是通过以下技术方案实现的:
一种治疗脱发、白发的提取液及其设备,包括:超声设备和提取液。
超声设备包括超声池和头罩,超声池由不锈钢容器5、上盖2和外壳10组成,不锈钢容器分布着超声波换能器1、半导体加热片12、温度传感器11;上盖有显示屏3,控制面板4,显示,3下方连接着控制线路板13,外壳由底台和四周壳体组成;
头罩为仿人体头部的网状结构,网格连接体7上分布着螺母和螺栓6,螺栓可以转动后调节伸出的长度。
提取液中包括迷迭香20-40份,松针20-40份,女贞子10-20份,旱莲草10-20份,含量0.8-0.9%氯化钠,以及由微量络氨酸酶、维生素B2、B6组成的辅助剂。
优选地,超声波的功率可以调节,功率值设定0.75-1.25W/cm2,进一步地,选择0.75-1.0W/cm2。
优选地,不锈钢容器四周及底部安装有超声波换能器1、半导体制热片12、温度传感器11。
优选地,显示屏3安装在上盖2,控制线路板13固定在外壳内侧,通过电缆与换能器1、半导体致热片12、温度传感器11连接。
优选地,外壳10、不锈钢容器5、上盖2通过螺栓连接。
优选地,头罩由附带螺母的网状塑料结构7及螺栓结构6组成。
进一步的,螺栓6由螺柱8和顶部的硅橡胶9组成
优选地,提取液包括:迷迭香10-40份,女贞子10-40份,旱莲草10-40份,含量0.8-0.9%氯化钠,以及由微量络氨酸酶、FGF-5S提取液、维生素B2、B6组成的辅助剂。
优选地,辅助剂中的FGF-5S是由从野蔷薇,银杏叶,地榆,枇杷叶中提取出的。
本发明的有益效果是:超声波和药液透过角质层15,通过改善毛囊16下后微动脉20、微静脉21组成的微循环,增加血流灌注量,影响毛乳头19、立毛肌18、肌纤维17、根鞘22,增加营养物质满足头发及头皮组织需要,治疗改善脱发和白发。
附图说明
图1为本发明一种治疗脱发、白发的提取液及其设备超声池结构示意图;
图2为本发明一种治疗脱发、白发的提取液及其设备不锈钢容器结构示意图;
图3为本发明一种治疗脱发、白发的提取液及其设备头罩结构示意图;
图4为本发明一种治疗脱发、白发的提取液及其设备治疗对象结构示意图;
具体实施方式
以下参照附图1-4,结合具体的实施方式对本发明做进一步的说明。
首先把配方中的原料组分称取后,粉碎混合,1:5的比例加0.8-0.9%氯化钠水,25摄氏度浸泡不低于20小时,过滤后形成提取液。提取液混合由微量络氨酸酶、维生素B2、B6组成的辅助剂,配成超声治疗用液,倒入超声池中;启动半导体加热,至合适的温度,将患者治疗部位浸入液体,与超声池壁及底部用头罩隔离。根据治疗部位的面积,按照0.75-1.25W/cm2设定超声波功率,每次10分钟左右为一疗程。通过改善头皮下血管的微循环,促进营养物质吸收,达到治疗脱发、白发目的,满足人们健康、美容的要求。
通过改善头皮下血管的微循环,促进营养物质吸收,达到治疗脱发、白发目的,满足人们健康、美容的要求。
当然应意识到,虽然通过通过本发明的实例已经进行了前面的描述,但是对本发明做出的将对本领域的技术人员显而易见的这样或其它的改进或改变应认为落入如本文提出的本发明宽广范围内。因此,尽管本发明已经参照了优选的实施方式进行描述,但是,其意并不是使具新颖性的设备由此而受到限制,相反,其旨在包括符合上述公开部分、权利要求的广阔范围之内的各种改进和等同修改。
Claims (6)
1.一种治疗脱发、白发的提取液及其设备,提取液包括:迷迭香10-40份,松针20-40份,女贞子10-40份,旱莲草10-40份,含量0.8-0.9%氯化钠,以及由微量络氨酸酶、FGF-5S提取液、维生素B2、B6组成的辅助剂;超声设备包括超声池、头罩、上盖、外壳及控制系统。将以上提取液及辅助剂、适量水倒入超声池,加热至选定温度,启动超声波,患者戴上头罩,将需治疗部位浸入超声池液体中,通过改善头皮血液微循环,刺激毛囊并促进毛发生长。
2.根据权利要求1所述的一种治疗脱发、白发的提取液及其设备,提取液配方是迷迭香10-40份,松针20-40份,女贞子10-40份,旱莲草10-40份,含量0.8-0.9%氯化钠;然后加入由微量络氨酸酶、FGF-5S提取液、维生素B2、B6组成的辅助剂混合而成。
3.根据权利要求1所述的一种治疗脱发、白发的提取液及其设备,超声设备包括超声池、头罩、上盖、外壳及控制系统。
4.根据权利要求1所述的一种治疗脱发、白发的提取液及其设备,辅助剂中的FGF-5S是由从野蔷薇,银杏叶,地榆,枇杷叶中提取出的。
5.根据权利要求1所述的一种治疗脱发、白发的提取液及其设备,超声波设备的功率是可以从0到100%调节。
6.根据权利要求1所述的一种治疗脱发、白发的提取液及其设备,头罩上的螺栓是可以调节的。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910304584.4A CN110025772A (zh) | 2019-04-16 | 2019-04-16 | 一种治疗脱发、白发的提取液及其设备 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910304584.4A CN110025772A (zh) | 2019-04-16 | 2019-04-16 | 一种治疗脱发、白发的提取液及其设备 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110025772A true CN110025772A (zh) | 2019-07-19 |
Family
ID=67238608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910304584.4A Pending CN110025772A (zh) | 2019-04-16 | 2019-04-16 | 一种治疗脱发、白发的提取液及其设备 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110025772A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117398315A (zh) * | 2023-11-08 | 2024-01-16 | 珠海欧维斯科技有限公司 | 一种促进毛囊生发的组合物及其制备方法 |
-
2019
- 2019-04-16 CN CN201910304584.4A patent/CN110025772A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117398315A (zh) * | 2023-11-08 | 2024-01-16 | 珠海欧维斯科技有限公司 | 一种促进毛囊生发的组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102920641B (zh) | 一种中药足浴粉及其加工方法和使用方法 | |
CN100387217C (zh) | 酵素健身浴粉末及制备方法 | |
WO2018000665A1 (zh) | 一种能让乳房丰满紧致和预防乳腺疾病的精华液 | |
CN109172491A (zh) | 一种具有抗衰老和活血化瘀功能的霜剂及其制备方法 | |
CN106729624A (zh) | 调节内分泌的抗衰老生物制剂、制备方法及其应用 | |
CN110025772A (zh) | 一种治疗脱发、白发的提取液及其设备 | |
CN1053568C (zh) | 草药健康美容产品 | |
CN1310227A (zh) | 一种保健食品及其生产方法 | |
CN110179708A (zh) | 一种植物赋活精油及制备方法 | |
RU2314085C2 (ru) | Способ проведения физиотерапевтической процедуры и паровая кабина для принятия физиотерапевтической процедуры | |
CN1060332C (zh) | 复方降压护发液及其制造方法 | |
CN200998412Y (zh) | 中药分子薰蒸治疗装置 | |
CN106552039A (zh) | 一种医治根骨痛症中药足浴养生保健方剂 | |
CN102100759A (zh) | 一种补益肝肾治疗骨质增生的中药组合物 | |
CN107320403A (zh) | 一种草珊瑚沐浴凝露 | |
CN107375428A (zh) | 一种氟西汀结合中药成分治疗白癜风的软膏及其制备方法 | |
CN103860450A (zh) | 一种外用美容抗衰老配方 | |
CN107929706A (zh) | 一种祛湿舒筋利骨的中药及其制备方法 | |
CN106692708A (zh) | 一种治疗骨科痈肿的本经膏药及其制备工艺 | |
CN103830633B (zh) | 一种藻类养生泡脚粉 | |
CN212940532U (zh) | 磁疗中药熏蒸装置 | |
CN107854551A (zh) | 一种烧伤止痛膏配方 | |
RU2299071C1 (ru) | Способ профилактики заболеваний | |
CN107865806A (zh) | 一种暖肤保湿身体乳及其制备方法 | |
Wang et al. | Traditional Chinese Medicine Cupping and Health |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190719 |